免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

BAROSTIM NEO Hypertension Pivotal Trial

NCT:NCT01679132 · COMPLETED

NCT编号NCT01679132
状态COMPLETED
开始日期2013-04-12
完成时间2025-07-23
SponsorCVRx, Inc. (INDUSTRY)
First posted
Last updated

简要摘要

The purpose of this clinical investigation (NCT01679132) is to assess the long-term safety and efficacy of the BAROSTIM NEO System in subjects currently participating in the BAROSTIM Hypertension Pivotal Trial (G120137).

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑